Shenzhen Kangmei biological Polytron Technologies
Latest round
- Series C
Last raised
- Sep 2013
Total raised
- $15M
Investors
- 3
About Shenzhen Kangmei biological Polytron Technologies
Established in 2007 and based in Shenzhen, China, Shenzhen Kangmei biological Polytron Technologies Inc. is a medical company that conducts research and development, production and sales of biomedical products. The company is headquartered in Shenzhen and has branches in Beijing and Wuhan. The company’s main business is the research and development of in vitro diagnostic reagents. The company’s self-developed products include nucleic acid detection kits for Neisseria gonorrhoeae, Chlamydia trachomatis, and Urea plasma urealyticum. Its products are used in the field of clinical diagnostics. The company generates revenue by providing diagnostic reagents and instruments.
Who invested in Shenzhen Kangmei biological Polytron Technologies
3 investors across 4 rounds
See all investors in Shenzhen Kangmei biological Polytron Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shenzhen Kangmei biological Polytron Technologies
Who invested in Shenzhen Kangmei biological Polytron Technologies?
Shenzhen Kangmei biological Polytron Technologies has 3 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shenzhen Kangmei biological Polytron Technologies raised?
Shenzhen Kangmei biological Polytron Technologies has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Shenzhen Kangmei biological Polytron Technologies last raise money?
Shenzhen Kangmei biological Polytron Technologies's most recent round on record is a Series C, in Sep 2013.
What does Shenzhen Kangmei biological Polytron Technologies do?
Established in 2007 and based in Shenzhen, China, Shenzhen Kangmei biological Polytron Technologies Inc.
Where is Shenzhen Kangmei biological Polytron Technologies headquartered?
Shenzhen Kangmei biological Polytron Technologies is headquartered in Shenzhen, China.
Which VCs invest in companies like Shenzhen Kangmei biological Polytron Technologies?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Shenzhen Kangmei biological Polytron Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Shenzhen Kangmei biological Polytron Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.